Sex Differences in Brain and Cognition in de novo Parkinson's Disease

Background and Objective: Brain atrophy and cognitive impairment in neurodegenerative diseases are influenced by sex. We aimed to investigate sex differences in brain atrophy and cognition in de novo Parkinson's disease (PD) patients.Methods: Clinical, neuropsychological and T1-weighted MRI dat...

Full description

Bibliographic Details
Main Authors: Javier Oltra, Carme Uribe, Anna Campabadal, Anna Inguanzo, Gemma C. Monté-Rubio, Maria J. Martí, Yaroslau Compta, Francesc Valldeoriola, Carme Junque, Barbara Segura
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.791532/full
_version_ 1798035261029875712
author Javier Oltra
Javier Oltra
Carme Uribe
Carme Uribe
Carme Uribe
Anna Campabadal
Anna Campabadal
Anna Inguanzo
Anna Inguanzo
Gemma C. Monté-Rubio
Maria J. Martí
Maria J. Martí
Maria J. Martí
Yaroslau Compta
Yaroslau Compta
Yaroslau Compta
Francesc Valldeoriola
Francesc Valldeoriola
Francesc Valldeoriola
Carme Junque
Carme Junque
Carme Junque
Barbara Segura
Barbara Segura
Barbara Segura
author_facet Javier Oltra
Javier Oltra
Carme Uribe
Carme Uribe
Carme Uribe
Anna Campabadal
Anna Campabadal
Anna Inguanzo
Anna Inguanzo
Gemma C. Monté-Rubio
Maria J. Martí
Maria J. Martí
Maria J. Martí
Yaroslau Compta
Yaroslau Compta
Yaroslau Compta
Francesc Valldeoriola
Francesc Valldeoriola
Francesc Valldeoriola
Carme Junque
Carme Junque
Carme Junque
Barbara Segura
Barbara Segura
Barbara Segura
author_sort Javier Oltra
collection DOAJ
description Background and Objective: Brain atrophy and cognitive impairment in neurodegenerative diseases are influenced by sex. We aimed to investigate sex differences in brain atrophy and cognition in de novo Parkinson's disease (PD) patients.Methods: Clinical, neuropsychological and T1-weighted MRI data from 205 PD patients (127 males: 78 females) and 69 healthy controls (40 males: 29 females) were obtained from the PPMI dataset.Results: PD males had a greater motor and rapid eye movement sleep behavior disorder symptomatology than PD females. They also showed cortical thinning in postcentral and precentral regions, greater global cortical and subcortical atrophy and smaller volumes in thalamus, caudate, putamen, pallidum, hippocampus, and brainstem, compared with PD females. Healthy controls only showed reduced hippocampal volume in males compared to females. PD males performed worse than PD females in global cognition, immediate verbal recall, and mental processing speed. In both groups males performed worse than females in semantic verbal fluency and delayed verbal recall; as well as females performed worse than males in visuospatial function.Conclusions: Sex effect in brain and cognition is already evident in de novo PD not explained by age per se, being a relevant factor to consider in clinical and translational research in PD.
first_indexed 2024-04-11T20:55:45Z
format Article
id doaj.art-8aae13a0fde948f29ac4fef4f44c830d
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-04-11T20:55:45Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-8aae13a0fde948f29ac4fef4f44c830d2022-12-22T04:03:42ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652022-01-011310.3389/fnagi.2021.791532791532Sex Differences in Brain and Cognition in de novo Parkinson's DiseaseJavier Oltra0Javier Oltra1Carme Uribe2Carme Uribe3Carme Uribe4Anna Campabadal5Anna Campabadal6Anna Inguanzo7Anna Inguanzo8Gemma C. Monté-Rubio9Maria J. Martí10Maria J. Martí11Maria J. Martí12Yaroslau Compta13Yaroslau Compta14Yaroslau Compta15Francesc Valldeoriola16Francesc Valldeoriola17Francesc Valldeoriola18Carme Junque19Carme Junque20Carme Junque21Barbara Segura22Barbara Segura23Barbara Segura24Medical Psychology Unit, Department of Medicine, Institute of Neurosciences, University of Barcelona, Barcelona, SpainInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainMedical Psychology Unit, Department of Medicine, Institute of Neurosciences, University of Barcelona, Barcelona, SpainInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainResearch Imaging Centre, Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, University of Toronto, Toronto, ON, CanadaMedical Psychology Unit, Department of Medicine, Institute of Neurosciences, University of Barcelona, Barcelona, SpainInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainMedical Psychology Unit, Department of Medicine, Institute of Neurosciences, University of Barcelona, Barcelona, SpainInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainMedical Psychology Unit, Department of Medicine, Institute of Neurosciences, University of Barcelona, Barcelona, SpainInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Hospital Clínic de Barcelona, Barcelona, SpainParkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Institute of Neurosciences, University of Barcelona, Barcelona, SpainInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Hospital Clínic de Barcelona, Barcelona, SpainParkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Institute of Neurosciences, University of Barcelona, Barcelona, SpainInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Hospital Clínic de Barcelona, Barcelona, SpainParkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Institute of Neurosciences, University of Barcelona, Barcelona, SpainMedical Psychology Unit, Department of Medicine, Institute of Neurosciences, University of Barcelona, Barcelona, SpainInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Hospital Clínic de Barcelona, Barcelona, SpainMedical Psychology Unit, Department of Medicine, Institute of Neurosciences, University of Barcelona, Barcelona, SpainInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Hospital Clínic de Barcelona, Barcelona, SpainBackground and Objective: Brain atrophy and cognitive impairment in neurodegenerative diseases are influenced by sex. We aimed to investigate sex differences in brain atrophy and cognition in de novo Parkinson's disease (PD) patients.Methods: Clinical, neuropsychological and T1-weighted MRI data from 205 PD patients (127 males: 78 females) and 69 healthy controls (40 males: 29 females) were obtained from the PPMI dataset.Results: PD males had a greater motor and rapid eye movement sleep behavior disorder symptomatology than PD females. They also showed cortical thinning in postcentral and precentral regions, greater global cortical and subcortical atrophy and smaller volumes in thalamus, caudate, putamen, pallidum, hippocampus, and brainstem, compared with PD females. Healthy controls only showed reduced hippocampal volume in males compared to females. PD males performed worse than PD females in global cognition, immediate verbal recall, and mental processing speed. In both groups males performed worse than females in semantic verbal fluency and delayed verbal recall; as well as females performed worse than males in visuospatial function.Conclusions: Sex effect in brain and cognition is already evident in de novo PD not explained by age per se, being a relevant factor to consider in clinical and translational research in PD.https://www.frontiersin.org/articles/10.3389/fnagi.2021.791532/fullParkinson's diseasesex differencesmagnetic resonance imaginggray matter atrophycognitive impairment
spellingShingle Javier Oltra
Javier Oltra
Carme Uribe
Carme Uribe
Carme Uribe
Anna Campabadal
Anna Campabadal
Anna Inguanzo
Anna Inguanzo
Gemma C. Monté-Rubio
Maria J. Martí
Maria J. Martí
Maria J. Martí
Yaroslau Compta
Yaroslau Compta
Yaroslau Compta
Francesc Valldeoriola
Francesc Valldeoriola
Francesc Valldeoriola
Carme Junque
Carme Junque
Carme Junque
Barbara Segura
Barbara Segura
Barbara Segura
Sex Differences in Brain and Cognition in de novo Parkinson's Disease
Frontiers in Aging Neuroscience
Parkinson's disease
sex differences
magnetic resonance imaging
gray matter atrophy
cognitive impairment
title Sex Differences in Brain and Cognition in de novo Parkinson's Disease
title_full Sex Differences in Brain and Cognition in de novo Parkinson's Disease
title_fullStr Sex Differences in Brain and Cognition in de novo Parkinson's Disease
title_full_unstemmed Sex Differences in Brain and Cognition in de novo Parkinson's Disease
title_short Sex Differences in Brain and Cognition in de novo Parkinson's Disease
title_sort sex differences in brain and cognition in de novo parkinson s disease
topic Parkinson's disease
sex differences
magnetic resonance imaging
gray matter atrophy
cognitive impairment
url https://www.frontiersin.org/articles/10.3389/fnagi.2021.791532/full
work_keys_str_mv AT javieroltra sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT javieroltra sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT carmeuribe sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT carmeuribe sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT carmeuribe sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT annacampabadal sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT annacampabadal sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT annainguanzo sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT annainguanzo sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT gemmacmonterubio sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT mariajmarti sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT mariajmarti sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT mariajmarti sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT yaroslaucompta sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT yaroslaucompta sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT yaroslaucompta sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT francescvalldeoriola sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT francescvalldeoriola sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT francescvalldeoriola sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT carmejunque sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT carmejunque sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT carmejunque sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT barbarasegura sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT barbarasegura sexdifferencesinbrainandcognitionindenovoparkinsonsdisease
AT barbarasegura sexdifferencesinbrainandcognitionindenovoparkinsonsdisease